Keyword → CI

Fed Minutes Reveal Deep Divide on Rate Path as Powell Succession Looms

Minutes from the Federal Reserve's January policy meeting, released Wednesday, showed officials broadly endorsing a pause in rate cuts but sharply divided on what comes next, with some members open to resuming easing if inflation continues to cool and others arguing for an extended hold — a split that is amplifying market uncertainty ahead of Friday's critical GDP and PCE data release.

Walmart Fourth Quarter Earnings Tomorrow to Provide Critical Read on U.S. Consumer Resilience

Walmart will report fiscal fourth quarter 2026 results before market open Thursday, with analysts forecasting adjusted EPS of $0.73 and revenue between $188.6-$190.5 billion. The report represents a pivotal test for the $1 trillion retailer following a 43-day government shutdown and carries outsized importance as a barometer of American consumer health amid a K-shaped recovery that has seen Walmart capture 75% of market share gains from households earning over $100,000.

Palo Alto Networks Reports Fiscal Q2 After Close as Cybersecurity Sector Watches Platformization Metrics

Palo Alto Networks is set to release fiscal second-quarter 2026 results after U.S. markets close Tuesday, with analysts projecting revenue of approximately $2.58 billion and non-GAAP EPS of $0.93 to $0.95. Investors will closely scrutinize Next-Generation Security ARR growth and customer platformization adoption as key indicators of the cybersecurity giant's long-term trajectory amid a decelerating top-line growth backdrop and intensifying enterprise software competition.

Rivian Soars 26% on Aggressive 2026 Delivery Forecast as R2 SUV Launch Approaches

Rivian Automotive shares rocketed 26.6% on Friday after the electric vehicle maker projected 2026 deliveries of 62,000 to 67,000 vehicles—representing 47% to 59% growth over 2025—and confirmed its mass-market R2 SUV remains on track for second quarter customer deliveries. The rally erased concerns about the company's path to profitability and validated CEO RJ Scaringe's characterization of 2026 as "an inflection point" for the business.

January CPI Inflation Cools to 2.4%, Beating Expectations and Boosting Fed Rate Cut Hopes

Consumer prices rose just 2.4% annually in January, falling below the anticipated 2.5% and marking the slowest pace since May 2025. Core inflation also eased to 2.5%, its lowest level since March 2021, providing relief to markets and strengthening the case for Federal Reserve rate cuts in 2026.

Federal Reserve Rate Cut Expectations Rise as Bond Yields Fall Following Tame Inflation Data

Treasury yields declined sharply following better-than-expected January inflation data, with two-year yields approaching their lowest levels since October. Money markets now price in approximately 63 basis points of Federal Reserve rate cuts in 2026, equivalent to around 50% odds of a third reduction by December.

Cisco Stock Plunges 11% Despite Earnings Beat as Margin Concerns Overshadow AI Infrastructure Gains

Cisco Systems reported better-than-expected second quarter fiscal 2026 results with revenue of $15.35 billion and adjusted EPS of $1.04, but shares tumbled 11% in Thursday trading as the company's profit margin guidance disappointed investors. Rising memory chip costs and tepid forward projections overshadowed robust AI infrastructure order growth of $2.1 billion.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

Philips Reports 2025 Results With Margin Expansion and 2026 Outlook Targets

Royal Philips published its full-year 2025 financial results, highlighting accelerated growth, expanding profit margins and robust cash flow. The company also unveiled strategic targets for 2026-2028, emphasizing innovation and operational efficiency across health technology segments.